2018 (Pre-intervention) n = 233 | 2019 (Post-intervention) n = 241 | p-value | |
---|---|---|---|
Age range | 89 (85–92) | 88 (84–93) | 0.02 |
median (IQR) | |||
Gender n (%) | 0.00 | ||
Female | 134 (57.5%) | 173 (71.8%) | |
Male | 99 (42.5%) | 68 (28.2%) | |
Medication total median (IQR) | 7 (4–11) | 8 (5–11) | 0.36 |
Medication missing n (%) | 24 (10.3%) | 23 (9.5%) | 0.78 |
Cognitive impairment n (%) | 151 (64.8%) | 183 (75.9%) | 0.01 |
Mobility prior to fall n (%) | 0.02 | ||
Non-ambulant Ambulant Not documented | 41 (17.6%) 176 (75.5%) 16 (6.9%) | 24 (10.0%) 210 (87.1%) 7 (2.9%) | |
FRAT risk n (%) | 0.00 | ||
High risk Not documented | 191 (82.0%) 42 (18.0%) | 224 (93.0%) 17 (7.0%) | |
Anticoagulation n (%) | 0.66 | ||
Anticoagulation No anticoagulation Not documented | 108 (46.4%) 117 (50.2%) 8 (3.4%) | 103 (42.7%) 131 (54.4%) 7 (2.9%) | |
Type of anticoagulation n (%) | 0.00 | ||
Antiplatelet DAPT Warfarin DOAC Antiplatelet + warfarin DAPT + DOAC or warfarin | 64 (27.5%) 1 (0.4%) 17 (7.3%) 18 (7.7%) 5 (2.1%) 0 (0.0%) | 48 (19.9%) 7 (2.9%) 12 (5.0%) 33 (13.7%) 0 (0%) 0 (0%) | |
LMWH Antiplatelet + LMWH Antiplatelet + DOAC | 0 (0%) 2 (0.9%) 1 (0.4%) | 0 (0%) 0 (0%) 3 (1.2%) | |
Witnessed fall n (%) | 0.13 | ||
Witnessed Not documented | 21 (9.0%) 15 (6.4%) | 26 (10.8%) 27 (11.2%) | |
Headstrike* n (%) | 0.75 | ||
Headstrike Not documented | 110 (47.2%) 78 (33.5%) | 118 (49.0%) 73 (30.3%) | |
Head injury** n (%) | 0.02 | ||
Head injury Not documented | 86 (37.0%) 89 (38.2%) | 105 (43.6%) 63 (26.1%) | |
Late presentation n (%) *** | 1 (0.4%) | 0 (0%) | 0.49 |
LOC n (%) | 0.33 | ||
LOC Not documented | 2 (0.9%) 121 (52.0%) | 6 (2.5%) 129 (53.5%) | |
Headache n (%) | 0.87 | ||
Headache Not documented | 14 (6.0%) 167 (71.7%) | 15 (6.2%) 177 (73.4%) | |
Vomiting n (%) | 0.08 | ||
Vomiting Not documented | 10 (4.3%) 191 (82.0%) | 9 (3.7%) 180 (74.7%) | |
Neurological deficits n (%) | 4 (1.7%) | 5 (2.1%) | 0.78 |
Change in GCS n (%) | 0.19 | ||
Change in GCS No change in GCS Not documented | 23 (9.9%) 160 (68.7%) 50 (21.5%) | 23 (9.5%) 149 (61.8%) 69 (28.6%) | |
GCS in ED n (%) | 0.45 | ||
Not documented < 13 ≥13 | 6 (2.6%) 27 (11.5%) 200 (85.8%) | 2 (0.8%) 18 (7.4%) 221 (91.7%) |